Friday, December 3, 2021

Regulus Therapeutics Names VP

San Diego-based Regulus Therapeutics, a biopharmaceuticals firm focused on targeted microRNA, said it has named Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceutical Development. Ahmadian previously was Vice President & Resident Director of Kinovate Life Sciences, and also previously served at Nitto Denko Technical Corporation.